secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMPACT BIOMEDICAL INC. (IBO)
CIK:        0001834105
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0001493152-24-043558
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Impact Biomedical furnishes investor presentation; no specific financial updates disclosed
--------------------------------------------------------------------------------

- COO Mark Suseck began delivering investor presentations on November 4, 2024.
- Presentation slide deck furnished as Exhibit 99.1; no new financial data or guidance in the filing.
- Company does not assume obligation to update the presentation information.
- No material operational metrics, revenue, or earnings figures provided in the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834105/000149315224043558/0001493152-24-043558-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834105/000149315224043558/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-043558

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer